Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Head & Neck Year : 2022

Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass

Abstract

Background To assess the impact of nutritional status on tolerance to induction chemotherapy by docetaxel, cisplatin and 5-fluorouracil (ICT) in head and neck cancer (HNC). Methods Ninety-two HNC patients were included. Toxicity was assessed according to common terminology criteria for adverse events. Nutritional status was assessed by body mass index (BMI), serum albumin, nutritional risk index (NRI), and CT scan (skeletal muscle mass index [SMI] at the first lumbar vertebral level). Results Before treatment, average BMI was 22.7 +/- 4.6 kg/m(2), serum albumin 38.7 +/- 5.8 g/L, NRI 97.6 +/- 10.6, and SMI 36.4 +/- 7.9 cm(2)/m(2). After treatment, BMI was 23 +/- 4.5, serum albumin 30.2 +/- 7.1, and NRI 88.1 +/- 9.2. During ICT, 52 (62%) patients developed at least one toxicity >= Grade 3. Pre-treatment SMI was the only predictive factor of toxicity irrespective of BMI (p = 0.04). Conclusion Low skeletal muscle mass is a predictive factor of toxicity to ICT in HNC.
No file

Dates and versions

hal-03636768 , version 1 (11-04-2022)

Licence

Identifiers

Cite

Alexane Lere‐chevaleyre, Maureen Bernadach, Céline Lambert, Lucie Cassagnes, Mathilde Puechmaille, et al.. Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass. Head & Neck, 2022, 44 (3), pp.681-690. ⟨10.1002/hed.26954⟩. ⟨hal-03636768⟩
32 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More